Antifreeze proteins (AFPs) are a structurally diverse group of proteins that have the ability to modify ice crystal structure and inhibit recrystallization of ice. AFPs are well characterized in fish and insects, but very few bacterial species have been shown to have AFP activity to date. Thirty eight freshwater to hypersaline lakes in the Vestfold Hills and Larsemann Hills of Eastern Antarctica were sampled for AFPs during 2000. Eight hundred and sixty six bacterial isolates were cultivated. A novel AFP assay, designed for high-throughput analysis in Antarctica, demonstrated putative activity in 187 of the cultures. Subsequent analysis of the putative positive isolates showed 19 isolates with significant recrystallization inhibition (RI) activity. The 19 RI active isolates were characterized using ARDRA (amplified rDNA restriction analysis) and 16S rDNA sequencing. They belong to genera from the alpha- and gamma-Proteobacteria, with genera from the gamma-subdivision being predominant. The 19 AFP-active isolates were isolated from four physico-chemically diverse lakes. Ace Lake and Oval Lake were both meromictic with correspondingly characteristic chemically stratified water columns. Pendant Lake was a saline holomictic lake with different chemical properties to the two meromictic lakes. Triple Lake was a hypersaline lake rich in dissolved organic carbon and inorganic nutrients. The environments from which the AFP-active isolates were isolated are remarkably diverse. It will be of interest, therefore, to elucidate the evolutionary forces that have led to the acquisition of functional AFP activity in microbes of the Vestfold Hills lakes and to discover the role the antifreezes play in these organisms.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1099/mic.0.26610-0 | DOI Listing |
Front Immunol
January 2025
Department of Hematology and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Immune dysfunction is one of the hallmarks of cancer and plays critical roles in immunotherapy resistance, but there is no serum biomarker that can be used to evaluate immune-dysfunction status of cancer patients. Here, we identified subtype-specific human endogenous retrovirus K102 envelope (HERV-K102-Env) with immunosuppressive activity in circulating blood as a novel serum immunosuppressive biomarker of cancer. We first generated monoclonal antibodies against K102-Env with high sensitivity and specificity, and we developed an ELISA assay to detect serum K102-Env.
View Article and Find Full Text PDFPLoS One
January 2025
Department of Surgery, Asian Liver Center, Stanford University School of Medicine, Stanford, California, United States of America.
Patients with chronic hepatitis B infection (CHB) have an increased risk for death from liver cirrhosis and hepatocellular carcinoma (HCC). In the United States, only an estimated 37% of adults with chronic hepatitis B diagnosis without cirrhosis receive monitoring with at least an annual alanine transaminase (ALT) and hepatitis B deoxyribonucleic acid (DNA), and an estimated 59% receive antiviral treatment when they develop active hepatitis or cirrhosis. A Markov model was used to calculate the costs, health impact and cost-effectiveness of increased monitoring of adults with HBeAg negative inactive or HBeAg positive immune tolerant CHB who have no cirrhosis or significant fibrosis and are not recommended by the current American Association for the Study of Liver Diseases (AASLD) clinical practice guidelines to receive antiviral treatment, and to assess whether the addition of HCC surveillance would be cost-effective.
View Article and Find Full Text PDFQuant Imaging Med Surg
January 2025
Department of Nuclear Medicine, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Background: Accurately differentiating hepatocellular carcinoma (HCC) from intrahepatic cholangiocarcinoma (ICC) is essential for therapeutic decision-making. This study aimed to explore the value of Fluor 18 (F)-conjugated fibroblast-activation protein inhibitor (FAPI-42) positron emission tomography-computed tomography (PET/CT) in distinguishing HCC from ICC preoperatively.
Methods: Patients with suspected intrahepatic lesions who underwent F-FAPI-42 PET/CT were retrospectively assessed and placed into an HCC group and an ICC group based on postoperative pathology.
Cureus
December 2024
Hematology and Medical Oncology, University of Kentucky College of Medicine, Lexington, USA.
Carcinoma of unknown primary (CUP) is a diverse group of malignancies characterized by metastatic disease without an identified primary site. It typically presents with a poor prognosis due to widespread metastasis at diagnosis. This report discusses a 58-year-old female patient with advanced CUP and diffuse liver metastasis.
View Article and Find Full Text PDFCureus
December 2024
Department of Hepatology, Gastroenterology, and Infectious Diseases, Al-Azhar University, Assiut, EGY.
Background There is ongoing debate regarding the impact of direct-acting antiviral drugs (DAAs) on the occurrence of de novo hepatocellular carcinoma (HCC). Vascular endothelial growth factor (VEGF) plays a crucial role in the development and angiogenesis of HCC. Aim This study aims to evaluate dynamic changes in vascular endothelial growth factor (VEGF) levels at different point times during and after treatment of HCV to evaluate the risk of de novo HCC in DAAs-treated HCV patients.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!